NSE: ZYDUSWELL · 3 November 2026
- Zydus Wellness Ltd. shares advanced 2.08% to close at ₹493.35 on Tuesday, moving within an intraday range of ₹468.55 and ₹525.45 after opening at ₹485.05.
- In response to an exchange clarification request regarding a media report about FSSAI notices over product claims, the company confirmed it received a standard notice on September 24, 2026, and submitted its response on October 4, 2026. Zydus Wellness clarified that statements appearing on product labels are factual and supported by scientific substantiation, maintaining that the article has no material negative financial impact on operations.
- Trading volume was 36.38 times the 20-day average daily volume.
Why is Zydus Wellness share price rising on 3 November 2026?
Zydus Wellness Ltd. shares advanced 2.08% to close at ₹493.35 on Tuesday, moving within an intraday range of ₹468.55 and ₹525.45 after opening at ₹485.05.
The broader market and sector environment showed strong upward momentum, as the Nifty index gained 1.58% and the Nifty FMCG sector surged 3.65%. Zydus Wellness participated in this broader industry strength, posting a 5-day return of 4.52% and a 20-day return of 1.97%, alongside a prior session return of 4.44%.
On the corporate front, the company released its financial results for the quarter ended September 30, 2026, reporting a consolidated net sales growth of 74.6% to ₹11,227 million compared to ₹6,429 million in the corresponding period of the previous year, while EBITDA reached ₹855 million. While these strong quarterly earnings figures provide fundamental context for the company's operational performance, market participants also noted recent regulatory interactions, including clarifications provided to exchanges regarding an FSSAI notice on product claims for which the company stated its label statements are factual and scientifically substantiated.
36.29 lakh shares traded by 3 November 2026 · 03:25 PM IST. This compares with a 20-day average daily volume of 99,770 shares (36.38 times). The five-day average daily volume was 83,801 shares. Separately, the NSE report for 2 November 2026 showed 34,801 shares delivered, representing 41.97% of that day’s traded volume. The same report recorded 8,200 trades.
The 2.08% gain is supported by the release of Q2 FY27 financial results showing a 74.6% increase in consolidated net sales alongside a strong rally across the Nifty FMCG sector and elevated trading volumes.
Latest Company Developments
In response to an exchange clarification request regarding a media report about FSSAI notices over product claims, the company confirmed it received a standard notice on September 24, 2026, and submitted its response on October 4, 2026. Zydus Wellness clarified that statements appearing on product labels are factual and supported by scientific substantiation, maintaining that the article has no material negative financial impact on operations.
Addresses regulatory inquiries transparently and reassures investors regarding compliance and product label integrity.
The company announced the appointment of Mr. Kapil Sharma as the Chief Revenue Officer, forming part of the senior management team. The update was duly submitted to the stock exchanges as part of ongoing management structuring.
Strengthens senior leadership to drive commercial execution and distribution expansion across retail and digital channels.
Significant increase in volume has been observed in Zydus Wellness Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zydus Wellness Limited has submitted their response.
The exchange sought clarification from the company regarding a recent media report. Such a request is a verification step and does not by itself confirm the reported issue.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 18.72% on 30 September 2026. This compares with 18.73% on 30 June 2026, a change of -0.01 percentage points.
The filing reported 24 MF/UTI holders.
Research & Brokerage Views
Maintained a Buy rating with a target price of ₹665 following previous quarterly reviews, reflecting confidence in the brand portfolio.
What to Watch Next
- Execution of growth strategies across Everyuth, Complan, and Sugar Free product portfolios
- Further updates on regulatory compliance and responses to regulatory authorities
- Sustained delivery volumes and participation relative to the 20-day average volume
- Performance of newly launched variants such as RiteBite Max Protein Crunchy Cookies
Other Dated Coverage
- Zydus Wellness Share Price Today: Why ZYDUSWELL Is Falling 1.78% | 28 October 2026 — 28 October 2026
More Zydus Wellness news and dated analysis →
Frequently Asked Questions
What is the latest Zydus Wellness company news?
In response to an exchange clarification request regarding a media report about FSSAI notices over product claims, the company confirmed it received a standard notice on September 24, 2026, and submitted its response on October 4, 2026. Zydus Wellness clarified that statements appearing on product labels are factual and supported by scientific substantiation, maintaining that the article has no material negative financial impact on operations.
How strong was Zydus Wellness’s trading volume?
36.29 lakh shares traded, 36.38 times the 20-day average daily volume. The price and volume data are dated 3 November 2026 · 03:25 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.